APTO - Four Healthcare Stocks Looking To Kick Off a Strong Month
CORAL GABLES, FL / ACCESSWIRE / March 1, 2019 / The healthcare stock market takes its cues from companies in the healthcare industry, and because these companies have shown impressive growth in the first few months of the new year, the surrounding market has responded favorably. Perhaps the most significant issue plaguing healthcare is the fact that access to qualitative care is far from equal on a global scale. Unlike other industries, healthcare has the unique opportunity, and responsibility, of creating innovating products purposed with improving the health/quality of life of consumers. With the advent of new medical technologies and approaches to treating patients suffering from a myriad of diseases, companies in the healthcare sector are attracting investors looking for lucrative opportunities. Premier Health Group (OTC: PHGRF) (CSE: PHGI), Midatech Pharma plc (NASDAQ: MTP), Aptose Biosciences Inc (NASDAQ: APTO), and Restoration Robotics Inc (NASDAQ: HAIR) represent 4 healthcare stocks picking up speed on Friday.
Premier Health Group (OTC: PHGRF) (CSE: PHGI) is a company which is laser-focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies to create a patient-centric healthcare framework to improve the quality of life for its patient network.
Premier Health Group (OTC: PHGRF) (CSE: PHGI) announced yesterday the launch of at technology-enabled mental health counseling service for patients in urban centers and remote and underserved populations. Dr. Tahmeena Ali and Dr. Robert McKenzie are two Vancouver-based family physicians with extensive experience in mental health care and will be championing the initiative. Mental health has become something of a taboo to discuss, let alone seek treatment, and Premier is taking the steps to help their patients receive the care they need.
Following the announcement, Dr. Essam Hamza, CEO of Premier Health Group (OTC: PHGRF) (CSE: PHGI), commented, "it's disheartening to hear that 1 in 5 people in Canada will personally experience a mental health problem or illness and due to the lack of accessibility to care providers, we are failing to meet the needs of mental health care provision. Having the ability to offer virtual mental health counseling services is pivotal to our patient-centric app. Through my own practice, I have encountered a significant number of teens and young adults who would much rather use virtual services from the comfort of their home than come in person and wait in a busy waiting room to talk about their mental health."
For More Information On Premier Health Group, Click Here
Midatech Pharma plc (MTP) made headlines this past week when the Company announced that further to the announcement made on 29 January 2019 and following the approval at yesterday's general meeting by shareholders of the strategic investment by China Medical Systems Holdings Limited group and A&B, the license agreement entered into by the Company and CMS is now formally in force.
Following the announcement, Dr. Craig Cook, CEO of Midatech, said, "we are delighted to finalize the license agreement with China Medical Systems, a leading Hong Kong-based Chinese pharmaceutical company. This is a key collaboration for Midatech that provides a strong endorsement of our technologies and pipeline whilst establishing a solid foundation for a successful and ambitious long-term partnership. The agreement will enable development of current and new products and extend our reach to the important markets of China and South East Asia."
For More Information On Midatech Pharma plc, Click Here
Aptose Biosciences Inc (APTO), a clinical-stage biotechnology company developing agents that target the dysregulated processes and signaling pathways of cancer cells and unmet medical needs of patients with life-threatening hematologic cancers, announced earlier this week that the Company will release its financial results for the quarter and year ended December 31, 2018, on Tuesday. March 12, 2019, after the close of the market.
In addition to this, the Company will present preclinical data for CG-806, its first highly potent oral small molecule pan-FLT3/pan-BTK inhibitor, and APTO-253, its MYC inhibitor, at their upcoming annual meeting.
For More Information on Aptose Biosciences Inc, Click Here
Restoration Robotics Inc (HAIR) announced earlier this week that the Company will showcase its ARTAS iXâ„¢ Robotic Hair Restoration System (the "ARTAS System") at the 2019 American Academy of Dermatology (AAD) Annual Meeting, being held March 1-3 at the Walter E. Washington Convention Center in Washington, D.C.
Following the announcement, Ryan Rhodes, CEO of Restoration Robotics, said, "we are proud to showcase the ARTAS iX System at the annual meeting of the American Academy of Dermatology. This meeting is significant for the ARTAS iX System as we introduce our ground-breaking technology to the dermatology specialty that has a core focus on hair, skin, and nails - effectively enabling an additional platform for our company to generate new medical and patient awareness regarding the multitude of hair restoration benefits the ARTAS System offers."
For More Information On Restoration Robotics Inc, Click Here
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Contact Information:
SOURCE: StockPrice.com